Louisiana Voice

Last Saturday (Aug. 15) The Guardian featured a story of the poster boy for corruption and greed, Il Duce Trump, WAVING A WASHINGTON POST HEADLINE that proclaimed “Prescription drug prices record sharpest drop in more than 60 years.”

In classic Trumpian fashion, TACO Don tradition, Trump hitched up his Depends and proclaimed the drop in prices was all his doing, failing to mention that the article in reality attributed the decrease to his predecessor, Joe Biden.

It was a staged photo-op and he waved the printout of the headline under the noses of reporters, encouraging the press pool to record and photograph the momentous event for posterity—even though it was not the heralded 1500 percent price decrease he predicted a few months ago (it was actually 3.1 percent for July). “Prescription drug prices down more than at any time over 60 years,” he reiterated. “What else do I have to say?”

Well, what he could have said was the truth, that the Inflation Reduction Act of 2022 which required Medicare to negotiate the prices it pays drug companies.

Wait. You mean Medicare could not negotiate prices for drugs the way insurance companies do in the private sector? Why, that’s…that’s outrageous! Why couldn’t that be done?

For that, you can thank former Louisiana Congressman Billy Tauzin who represented Louisiana’s 3^rd congressional district from 1980 to 2005. The Chackbay Chameleon switched from Democrat to Repugnantcan in 1995 when the Repugs won control of congress so as not to lose seniority status and in 2004 chose not to run for reelection.

That decision wasn’t because he faced a threat of defeat. It was a financial decision, pure and simple, and we have higher drug prices for Medicare as a result. Of course, with an inability to negotiate on the part of Medicare had the ripple effect of causing higher insurance premiums as well.

So pay attention here. Like any game, politics included, it’s critical to keep your eye on the ball at all times.

You see, Tauzin was seeing dollar signs–big dollar signs–in his future when he made that 2024 announcement that he would not run again. That’s because he had been offered a cushy job of president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), beginning the day he left his congressional office in January 2005.

And how did he land such a powerful job? Why, in 2002, while still in office, he was appointed chairman of the House Energy & Commerce Committee which had—and has—jurisdiction over the drug industry and in 2004, his final year in office, he SPEARHEADED a Medicare prescription drug bill (coincidentally drafted by drug industry lobbyists) which prohibited Medicare from negotiating bulk discounts with drug companies. BINGO! Instant profiteering by Bib PhRMA! Would love to have seen the stock quotes for drug companies the day that measure passed.

The new law made the U.S. the only developed country whose legislative body voted to subject its citizens to unprotected increases, making medications ranging from moderate to life-saving unaffordable to some American, as much as 2.4 times higher than the average price of nine other developed countries. It is also why other counties enjoy vastly reduced bulk prices.

I’m sure there was no connection to be made but prior to being named chairman of the Energy and Commerce Committee, Tauzin’s total contributions to his campaigns by the drug lobby was $5,000. After his appointment, he received $91,000 from drug companies—and, apparently, free travel  

Page 6 of Tauzin’s 2003 financial report shows that PhRMA flew him from Washinton, D.C. to Naples, Florida, on March 27 of that year and back to Washington three days later, on March 30. Less than two years later, he was CEO of the organization.

So, bottom line, Tauzin, whose congressional salary was $154,000, turned his back on Medicare recipients (read: the elderly) to take a lobbying job that paid him $2 million a year.

And while the Inflation Reduction Act that reinstated negotiations was expected to reduce the annual federal deficit by as much as $25 billion, there were, as usual, the back-door political deals.

With the assistance of another Louisiana congressman, Speaker Mike Johnson, the House in July 2025 passed the Repugnantcan policy bill that handed Big PhRMA a hefty $5 billion bonus by allowing more medications to be exempt from Medicare’s price negotiation program

According to Rebecca Robins, writing for The New York Times, under existing law, expensive drugs are exempt from price negotiations if they are approved to treat a single rare disease that affects fewer than 200,000 patients. Drugmakers, in a somewhat convoluted argument, have maintained that the negotiation requirement discourages the conducting of studies and seeking approval to treat a second rare disease, and that it ultimately deprives patients of new treatments.

In response, the new bill spares drugs that are approved to treat multiple rare diseases. They can still be subject to price negotiations later if they are approved for larger groups of patients, though the exemption delays those reduced prices.

Meanwhile, Trump attempts to again take credit for something positive accomplished by one of his predecessors. He’s done it with Obama and now he’s doing it with a Biden-passed bill.

In military parlance, that’s similar to stolen valor on the part of Cadet Bonespurs.

I have found myself wondering on several occasions why no one has chosen to run against Mike Johnson who masquerades as a Christian while willingly betraying every known principle of Christianity with his pathetic tenure as House Speaker.

Today, I am happy to announce that someone has stepped forward to challenge Johnson, who is little more than an extension of Donald Trump.

I am fully aware that Louisiana is a deep red state but that is only because of Democrats’ failure to turn out in sufficient numbers to make their voices heard and their needs felt.

Republicans in the Louisiana Legislature reconfigured the state’s congressional districts, absorbing Lincoln, Jackson, Winn and part of Rapides Parish from the 5th District to the new 4th, hoping by making it the most solidly red district, they would protect Johnson. That is reflected in the 68.4 percent white and 20.1 percent black makeup of the district and should bode well for Johnson.

But his weak leadership and partisan politics could yet be his achilles heel. Ethnicity notwithstanding, the state is still fairly balanced in party registration with Democrats holding a slight edge in numbers.

If disillusioned Republicans (and they do exist), and both white and black Democrats can lay aside any differences they may have long enough to realize we all share a common need for health care, jobs, affordable housing and food, the results could be astounding.

With that in mind, I give you Conrad Cable, a vegetable farmer from Marion, in Union Parish:

Following is his announcement:

Book burning ceremony in Berlin shortly after Hitler assumed power

Member of Congress are notorious for passing laws that affect everyone but themselves. Case in point, they are not exempt from laws on such subjects as sexual harassment, health care and insider trading but they do have an annoying habit of being able to look the other way when there are obvious violations.

But one need only look back to the year 2024—just two short years ago—to see wholesale cases of insider trading by members of Congress in direct violation of the 2012 STOCK ACT prohibiting the use of non-public information for private profit.

And the examples of insider trading by one Donald J. Trump are far too numerous to even list here.

And LouisianaVoice and just about every Louisiana news outlet has carried stories of how Julia Letlow (1) violated the STOCK Act some 200 times by missing reporting deadlines on her trades and (2) invested in Meta, which is constructing a mammoth data center in her district, a transaction one outlet said carried “A TRULY CROOKED STENCH.”

So, to put its collective purity on display just before the midterm elections, Congress on July 22 magnanimously passed the STOP INSIDER TRADING ACT (SITA) which increases penalties for insider trading in Congress from (wait for it) $200 to $2,000 or 10 percent of the value of the transaction, whichever is greater.

Think about that. With some trades netting hundreds of thousands of dollars, a 10 percent fine is little more than a broker’s fee—certainly not to be considered a deterrent. It’s a shell game, folks, and we’re the marks. Letlow is a great example of that: she voted for the bill even as she took full advantage of the soft enforcement of House ethics rules—all while running for the U.S. Senate.

You’d think that a good ethics bill would get solid bipartisan backing but alas, it barely passed, by a 232-198 vote.

Why, you ask, did it not get stronger support? Well, because House Republicans attached a rider that included the bulk of H.B. 9368 that would require photo ID to vote in federal elections. It’s all part of Trump’s SAVE America Act which is aimed at disenfranchising minorities and the elderly.

It also requires states to submit voter rolls to a federal database for review, a request with which Louisiana’s secretary of state has already complied.

Those with long memories will remember that a computerized database was instrumental in disqualifying tens of thousands of voters in Ohio in 2004. Ohio was a swing state that Bush won in a razor-thin majority over John Kerry. That particular data base was employed to ensure the placement of plentiful number of voting machines in districts favorable to Bush and to ration the machines to districts leaning toward Kerry. The result was people waiting as long as 16 hours to vote in the latter districts while just the opposite was the case in the others.

It’s no secret that the SAVE America Act is simply a repeat of that tactic and Trump, with a historically low approval rating, is desperate to keep Republican majorities in each chamber.

So, why not attach a rider onto a bill that looks like a strong ethics bill in order to get what Republicans want? It’s an old trick and one which only contributes to the existing state of gridlock.

If you seriously think for one nano-second that the bill, which, by the way, is doomed for failure in the Senate anyway, will discourage insider trading, you probably believe Trump was on Air Force One when it left Turkey.